MY ACCOUNT | NEWSLETTER |

European Commission accelerates phasing out of animal testing


The European Commission recently responded to the European Citizens' Initiative (ECI) ‘Save Cruelty-free Cosmetics - Commit to a Europe without Animal Testing.'

The response provides a comprehensive overview of the EU's legislative and policy framework relevant to the use of animals for testing purposes. It also proposes additional actions to further reduce animal testing.

The Commission welcomes the initiative and acknowledges that animal welfare remains a strong concern for European citizens. It highlights the leading role of the EU in phasing out the use of animals in testing and improving animal welfare in general. This is especially reflected in the full ban of animal testing for cosmetics, which has been in place in the EU since 2013.

In addition, the Commission will launch a new roadmap with a set of legislative and non-legislative actions to further reduce animal testing, with the aim to ultimately move to an animal-free regulatory system under chemicals legislation (e.g. REACH, Biocidal Product Regulation, Plant Protection Products Regulation and human and veterinary medicines) and continue strongly supporting alternatives to animal testing.

In relation to the modernization of science, the Commission will continue its strong support to research for the development of alternatives to animal testing and explore the possibility to coordinate the activities of Member States in this field.

The Commission outlines the following actions in response to specific objectives of the European citizens' initiative:

  • Protect and strengthen the cosmetics animal testing ban: The Commission emphasizes that the EU Cosmetics Regulation already prohibits the placing on the market of cosmetic products that have been tested on animals. However, this ban does not extend to safety tests required to assess risks from chemicals to workers and the environment under the EU Regulation on the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH). The interface between the two pieces of legislation is currently being assessed in two cases before the Court of Justice of the European Union. The Commission will consider the outcome of the court cases in view of any future potential legislative changes.
  • Transform EU chemicals legislation: As part of its commitment to reducing and potentially eliminating animal testing in the context of chemicals legislation, the Commission will work together with all relevant parties on a roadmap towards chemical safety assessments that are free from animal testing. The roadmap will serve as a guiding framework for future actions and initiatives aimed at reducing and ultimately eliminating animal testing in the context of chemicals legislation within the European Union.
  • Modernize science in the EU: While the Commission does not share the view that a legislative proposal is required to reach the goal of phasing out the use of animals in research, training and education, it will continue to strongly support the development of alternative approaches with appropriate funding. The Commission is also proposing to initiate a series of actions to accelerate the reduction of animal testing in research, education and training, including exploring the possibility to coordinate the activities of the member states and national authorities in this field, exploratory workshops, and sustaining new training initiatives for early career scientists.

Read more on the commission's site. 

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Evaluation of 3D additively manufactured canine brain models for teaching veterinary neuroanatomy

Like0
Dislike0

Reasons for whole carcass condemnations of cattle in the United States and implications for producer education and veterinary intervention

Like0
Dislike0

A New Penn Vet Clinic Brings Support and Hope for Dogs with Retinal Disease

Like0
Dislike0

Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ to Advance Development of a Pan-Target, Programmable Therapeutic

Like0
Dislike0

Cooperation in regional innovation networks among small and medium enterprises: Case study of a veterinary pharmaceutical company in Jalisco, Mexico

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top